ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
미쎄라 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 284만 달러에서 2026년에는 300만 달러에 이르고, CAGR 5.7%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 신장질환 유병률 증가, 단시간 작용형 에리스로포이에틴 제제의 한계, 지속형 에리스로포이에틴 수용체 작용제의 임상적 유효성 확인, 투석 인프라 확충, 빈혈 관리 프로토콜의 개선 등이 주요 요인으로 꼽힙니다.
미쎄라 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 369만 달러에 이르고, CAGR은 5.3%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 고령화 인구 증가, 투석 환자 수 증가, 주사 빈도 감소에 대한 수요, 신장병 전문 클리닉 확대, CKD(만성콩팥병)에 대한 의료비 지출 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 지속형 ESA의 사용 증가, 투약 간격 연장 선호, CKD 환자 인구 증가, 투석 센터에서의 치료 증가, 안정적인 헤모글로빈 관리에 대한 관심 등이 있습니다.
만성콩팥병(CKD)의 유병률 증가는 향후 몇 년 동안 미르셀라 시장의 성장을 견인할 것으로 예측됩니다. 만성콩팥병(CKD)은 점진적인 신장 기능 저하를 특징으로 하는 병태로, 당뇨병이나 고혈압과 같은 질환과 관련이 있는 경우가 많습니다. CKD 발생률 증가에는 고령화, 생활습관 변화, 진단 능력 향상 등의 요인이 영향을 미치고 있습니다. CKD의 빈번한 합병증인 빈혈은 에리트로포이에틴 생산 감소로 인해 발생하며, 헤모글로빈 수치를 효과적으로 관리하고 유지하기 위해서는 미르셀라와 같은 적혈구 조혈 촉진제를 사용해야 합니다. 예를 들어, 2023년 6월 영국 비영리단체 'Kidney Research UK'가 발표한 자료에 따르면, 영국에서는 약 720만 명이 만성 신장 질환을 앓고 있으며, 이는 전체 인구의 10% 이상에 해당합니다. 2033년까지 이 숫자는 761만 명으로 늘어날 것으로 예측됩니다. 이처럼 CKD의 유병률 증가가 밀셀라 시장의 성장을 견인하고 있습니다.
미르셀라 시장의 주요 기업들은 CKD에 수반되는 빈혈을 치료하기 위해 특히 소아 환자를 위한 승인된 치료법 개발에 집중하고 있습니다. CKD 관련 빈혈이 있는 소아 환자에게는 장시간 작용하는 적혈구 조혈자극인자(ESA)인 미르셀라(메톡시 폴리에틸렌글리콜루에포에틴β)가 효과적입니다. 이 약은 적혈구 생성을 촉진하고, 잦은 주사의 필요성을 줄이며, 수혈의 위험을 줄이고, 헤모글로빈 수치를 개선하여 전반적인 성장과 발달 및 삶의 질(QOL)을 개선하는 데 기여합니다. 예를 들어, 2024년 4월 스위스에 본사를 둔 제약회사 비포 파마(Vifor Pharma)는 미셀라의 적응증 확대에 대해 FDA의 승인을 받았습니다. 이로써 생후 3개월부터 17세까지 CKD 관련 빈혈을 앓고 있는 소아 환자들에게도 사용이 가능해졌습니다. 이번 승인은 투석 환자와 비투석 환자 모두에게 적용되며, 특히 헤모글로빈 수치가 안정된 후 다른 ESA에서 전환하는 환자를 대상으로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 시장 규제 상황과 투자환경
제29장 경쟁 구도와 기업 개요
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 시장 잠재력이 높은 국가, 부문, 전략
제33장 부록
LSH
영문 목차
영문목차
Mircera is a medication specifically developed to treat anemia linked to chronic kidney disease (CKD). It is a long-acting erythropoiesis-stimulating agent (ESA) that encourages red blood cell production to help maintain healthy hemoglobin levels. Mircera is usually given via intravenous or subcutaneous injections and is notable for its extended dosing schedule, often requiring administration only once every two to four weeks.
The main formulations of Mircera are injectable solutions and pre-filled syringes. Anemia associated with chronic kidney disease occurs when individuals with CKD experience a reduction in red blood cells, resulting in anemia. Its indications include anemia due to chronic kidney disease and anemia in cancer patients. The medication is distributed through hospitals, dialysis centers, specialty clinics, and retail pharmacies and is used by various patient groups, including adults and geriatric patients.
Tariffs have affected the mircera market by increasing costs related to imported biologic raw materials, syringe systems, and cold chain distribution services. These effects are more pronounced in regions dependent on imported anemia therapies, including asia pacific and parts of latin america. Dialysis centers face procurement cost pressures impacting treatment budgets. However, tariffs have encouraged regional manufacturing and filling operations. This improves long term supply reliability and supports broader patient access to anemia treatments.
The mircera market research report is one of a series of new reports from The Business Research Company that provides mircera market statistics, including mircera industry global market size, regional shares, competitors with a mircera market share, detailed mircera market segments, market trends and opportunities, and any further data you may need to thrive in the mircera industry. This mircera market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mircera market size has grown strongly in recent years. It will grow from $2.84 million in 2025 to $3 million in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising chronic kidney disease prevalence, limitations of short acting esas, clinical validation of continuous erythropoietin receptor activators, expansion of dialysis infrastructure, improved anemia management protocols.
The mircera market size is expected to see strong growth in the next few years. It will grow to $3.69 million in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growth in aging population, increasing dialysis patient numbers, demand for reduced injection frequency, expansion of specialty nephrology clinics, rising healthcare spending on ckd. Major trends in the forecast period include rising use of long acting esas, preference for extended dosing intervals, growing ckd patient population, increased treatment in dialysis centers, focus on stable hemoglobin management.
The rising prevalence of chronic kidney disease (CKD) is expected to drive the growth of the Mircera market in the coming years. Chronic kidney disease (CKD) is a medical condition marked by the gradual decline of kidney function, often linked to diseases such as diabetes and hypertension. The growing incidence of CKD is influenced by factors including aging populations, lifestyle changes, and improved diagnostic capabilities. Anemia, a frequent complication of CKD caused by reduced erythropoietin production, necessitates the use of erythropoiesis-stimulating agents like Mircera to effectively manage and maintain hemoglobin levels. For example, in June 2023, Kidney Research UK, a UK-based non-profit organization, reported that approximately 7.2 million people in the UK were living with chronic kidney disease, representing over 10% of the population. By 2033, this number is projected to increase to 7.61 million. Thus, the rising prevalence of CKD is driving the Mircera market.
Key players in the Mircera market are focusing on developing approved therapies specifically for pediatric patients to treat anemia associated with CKD. Pediatric patients with CKD-related anemia can benefit from Mircera (methoxy polyethylene glycol-epoetin beta), a long-acting erythropoiesis-stimulating agent (ESA) that promotes red blood cell production, reduces the need for frequent injections, lowers the risk of blood transfusions, and improves hemoglobin levels, thereby supporting overall growth, development, and quality of life. For instance, in April 2024, Vifor Pharma, a Switzerland-based pharmaceutical company, received FDA approval to expand the use of Mircera to pediatric patients aged 3 months to 17 years with CKD-associated anemia. This approval applies to both dialysis and non-dialysis patients, particularly those transitioning from another ESA after their hemoglobin levels have stabilized.
In January 2023, AstraZeneca plc, a UK-based biopharmaceutical company, acquired CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, in a deal valued at up to $1.8 billion. Through this acquisition, AstraZeneca aims to strengthen its cardiorenal pipeline by acquiring Baxdrostat (CIN-107), a highly selective oral aldosterone synthase inhibitor targeting hypertension and CKD. CinCor Pharma focuses on developing novel small-molecule therapies for treatment-resistant hypertension, primary aldosteronism, and other cardiorenal disorders.
Major companies operating in the mircera market are Roche
North America was the largest region in the mircera market in 2025. The regions covered in the mircera market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mircera market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
The mircera market consists of sales of solutions and pre-filled syringes designed to treat anemia caused by chronic kidney disease (CKD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mircera Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mircera market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mircera ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mircera market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Formulation: Injectable Solution; Pre-filled Syringes
2) By Indication: Anemia Due to Chronic Kidney Disease; Anemia in Cancer Patients
3) By Distribution Channel: Hospitals; Dialysis Centers; Specialty Clinics; Retail Pharmacies
4) By End User Patients: Adult Patients; Geriatric Patients
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Use Of Long Acting Esas
4.2.2 Preference For Extended Dosing Intervals
4.2.3 Growing Ckd Patient Population
4.2.4 Increased Treatment In Dialysis Centers
4.2.5 Focus On Stable Hemoglobin Management
5. Mircera Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Dialysis Centers
5.3 Nephrology Clinics
5.4 Specialty Clinics
5.5 Home Care Providers
6. Mircera Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Mircera Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Mircera PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Mircera Market Size, Comparisons And Growth Rate Analysis
7.3. Global Mircera Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Mircera Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Mircera Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Mircera Market Segmentation
9.1. Global Mircera Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable Solution, Pre-filled Syringes
9.2. Global Mircera Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Anemia Due To Chronic Kidney Disease, Anemia in Cancer Patients
9.3. Global Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.4. Global Mircera Market, Segmentation By End User Patients, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adult Patients, Geriatric Patients
10. Mircera Market Regional And Country Analysis
10.1. Global Mircera Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Mircera Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Mircera Market
11.1. Asia-Pacific Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Mircera Market
12.1. China Mircera Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Mircera Market
13.1. India Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Mircera Market
14.1. Japan Mircera Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Mircera Market
15.1. Australia Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. South Korea Mircera Market
16.1. South Korea Mircera Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
16.2. South Korea Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. Western Europe Mircera Market
17.1. Western Europe Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. Western Europe Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. UK Mircera Market
18.1. UK Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Germany Mircera Market
19.1. Germany Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. France Mircera Market
20.1. France Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Eastern Europe Mircera Market
21.1. Eastern Europe Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Eastern Europe Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. North America Mircera Market
22.1. North America Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
22.2. North America Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. USA Mircera Market
23.1. USA Mircera Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
23.2. USA Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Canada Mircera Market
24.1. Canada Mircera Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
24.2. Canada Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. South America Mircera Market
25.1. South America Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
25.2. South America Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Middle East Mircera Market
26.1. Middle East Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Middle East Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Africa Mircera Market
27.1. Africa Mircera Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Africa Mircera Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Mircera Market Regulatory and Investment Landscape
29. Mircera Market Competitive Landscape And Company Profiles
29.1. Mircera Market Competitive Landscape And Market Share 2024
29.1.1. Top 10 Companies (Ranked by revenue/share)
29.2. Mircera Market - Company Scoring Matrix
29.2.1. Market Revenues
29.2.2. Product Innovation Score
29.2.3. Brand Recognition
29.3. Mircera Market Company Profiles
29.3.1. Roche Overview, Products and Services, Strategy and Financial Analysis
30. Global Mircera Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Mircera Market
32. Mircera Market High Potential Countries, Segments and Strategies
32.1 Mircera Market In 2030 - Countries Offering Most New Opportunities
32.2 Mircera Market In 2030 - Segments Offering Most New Opportunities
32.3 Mircera Market In 2030 - Growth Strategies
32.3.1 Market Trend Based Strategies
32.3.2 Competitor Strategies
33. Appendix
33.1. Abbreviations
33.2. Currencies
33.3. Historic And Forecast Inflation Rates
33.4. Research Inquiries
33.5. The Business Research Company
33.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
